Clinical Trials Directory

Trials / Terminated

TerminatedNCT02762825

Novel Cardiac Rehabilitation in Patients Heart Failure and Preserved Ejection Fraction

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Patients with HFpEF suffer from exercise intolerance, increased risk for hospitalization and mortality, and poor QOL. Unlike patients with HFrEF, no drug or device therapies appear to be consistently beneficial in treating these problems. However, increasing evidence suggests that exercise training is effective for both partially reversing exercise intolerance and improving quality of life in these patients. Most such trials to date have been conducted in controlled research setting, versus integrating these patients in to a standard CR program. Also, since functional capacity is related to outcomes in these patients, exercise strategies aimed at further improving fitness are warranted. One such strategy is using higher intensity interval training (HIIT) in the CR setting, a strategy shown to be effective in patients with other types of CVD. This project is designed to test the feasibility of incorporating these patients into the CR setting, and training them using a methodology (i.e., HIIT) already shown to yield (in other patients with CVD) greater gains in fitness when compared to what was achieved using standard MCT alone.

Conditions

Interventions

TypeNameDescription
BEHAVIORALHIITHIIT will consist of 4 min of higher intensity work set at 90% of heart rate reserve, based on peak heart rate from CPX test. Recovery intervals will be 3-4 min in duration and set at 60-70% of heart rate reserve. Resistance training will be performed once per week.
BEHAVIORALMCTMCT will consist of aerobic exercise performed 3 times per week for 30 min each session, at an intensity of 60-80% of heart rate reserve, based on peak heart rate from CPX test.

Timeline

Start date
2016-03-01
Primary completion
2022-09-27
Completion
2022-09-27
First posted
2016-05-05
Last updated
2022-12-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02762825. Inclusion in this directory is not an endorsement.